Polydex Pharmaceuticals Ltd. (PC) Stock Price - POLXF

Best deals to access real time data!
DDE w/Realtime (Monthly)
Monthly Subscription
for only
Small Cap Pro
Monthly Subscription
for only
Canna Trader Pro
Monthly Subscription
for only
VAT not included
Company Name Stock Ticker Symbol Market Type
Polydex Pharmaceuticals Ltd. (PC) POLXF OTCMarkets Common Stock
  Price Change Change Percent Stock Price High Price Low Price Open Price Close Price Last Traded
  -0.059 -5.62% 0.991 1.02 0.991 1.02 1.05 16:58:11
Bid Price Ask Price Spread Spread % News
0.75 1.05 0.30 28.57% - -
Stock Trades Traded Volume VWAP Dollar Volume Average Volume 52 Week Range
3 3,270 $ 1.02 $ 3,335 4,741 0.7512 - 1.29
Last Trade Time Type Quantity Stock Price Currency
11:07:32 270 $ 0.991 USD

Polydex Pharmaceuticals Ltd. (PC) Financials

Market Cap Shares in Issue Profit/Loss Earnings Per Share (EPS) PE Ratio Float
$ 3.39M 3.42M $ -1.59M - - 2.39M
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
188.00 $ - 0.00% - -

more financials information »

Polydex Pharmaceuticals Ltd. (PC) News

Loading Messages....

Latest POLXF Messages

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical POLXF Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week1.051.100.9911.1013,763-0.059-5.62%
1 Month1.001.100.981.088,942-0.009-0.9%
3 Months1.111.110.951.0612,081-0.119-10.72%
6 Months0.7811.290.7811.0710,7280.2126.89%
1 Year0.851.290.75121.057,5010.14116.59%
3 Years1.401.88060.75121.124,890-0.409-29.21%
5 Years0.712.820.681.214,5950.28139.58%

Polydex Pharmaceuticals Ltd. (PC) Description

Polydex Pharmaceuticals Limited (the "Company") is engaged in the research, development, manufacture and marketing of biotechnology-based products for the veterinary and human pharmaceutical markets. This includes the manufacture of bulk pharmaceutical intermediates for the worldwide veterinary pharmaceutical industry. The Company focuses on the manufacture and sale of Dextran and derivative products, including Iron Dextran and Dextran Sulphate, and other specialty chemicals. Dextran, a generic name applied to certain synthetic compounds formed by bacterial growth on sucrose, is a polymer or giant molecule. The name Polydex combines the words "polymer" and "dextran." The Company conducts its business operations through its two wholly-owned subsidiaries/divisions. The manufacture and sale of Dextran and derivative products is conducted through Dextran Products, incorporated in Canada in 1966 (Dextran Products),and Chemdex Inc (Chemdex) which is incorporated in the state of Kansas, United States.FOR ADDITIONAL FINANCIAL INFORMATION AND NEWS, INCLUDING MORE RECENT QUARTERLY REPORTING, PLEASE VISIT OUR WEBSITE!

Your Recent History
Polydex Ph..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.